Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity (SMM)

NCT05429346 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT05429346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity (SMM)
Lead sponsor
Kaiser Permanente
Phase
Observational
Overall status
Unknown status
Start date
January 8, 2023
Completion date
April 30, 2026
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital herpes simplex, maternal morbidity, racial disparities